<br />
ONCOLOGY<br />
Reprints of Vol 6.1 • europeanmedical-journal.com<br />
INSIDE<br />
Review of<br />
ESMO 2018<br />
Munich, Germany<br />
<br />
<br />
<br />
Congress Review<br />
Review of the European Society for<br />
Medical Oncology (ESMO) Congress 2018<br />
R(ESMO)<br />
enting an essential platform for collective discussions on this year’s theme of<br />
ring access to optimal cancer care’, the European Society for Medical Oncology<br />
Congress 2018 welcomed >26,000 oncology professionals throug<br />
doors of the Internationales Congress Center München (ICM) in the heart of M<br />
Germany. Spanning 5 days, ESMO 2018 took place in the Bavarian capital from 19<br />
October and involved a balanced programme of sessions, discussions, present<br />
and debates. Herein, the EMJ provides their signature independent review of the co<br />
for your enjoyment; whether you missed the event or<a title="EMJ Oncology 2018 ePrint page 1" href="http://viewer.zmags.com/publication/5e9fb3a9?page=1"> ONCOLOGY Reprints of Vol 6.1 • europeanmedical-jo</a>
<a title="EMJ Oncology 2018 ePrint page 2" href="http://viewer.zmags.com/publication/5e9fb3a9?page=2"> </a>
<a title="EMJ Oncology 2018 ePrint page 3" href="http://viewer.zmags.com/publication/5e9fb3a9?page=3"> Congress Review Review of the European</a>
<a title="EMJ Oncology 2018 ePrint page 4" href="http://viewer.zmags.com/publication/5e9fb3a9?page=4"> During the next 4 days, a myriad of scientific ses</a>
<a title="EMJ Oncology 2018 ePrint page 5" href="http://viewer.zmags.com/publication/5e9fb3a9?page=5"> Short-Course Trastuzumab Proposals for Treatment </a>
<a title="EMJ Oncology 2018 ePrint page 6" href="http://viewer.zmags.com/publication/5e9fb3a9?page=6"> the clinical effectiveness results demonstrating </a>
<a title="EMJ Oncology 2018 ePrint page 7" href="http://viewer.zmags.com/publication/5e9fb3a9?page=7"> Financial Issues Impact Psychological Cancer Burd</a>
<a title="EMJ Oncology 2018 ePrint page 8" href="http://viewer.zmags.com/publication/5e9fb3a9?page=8"> Adherence to Cancer Screening: EDIFICE Results “I</a>
<a title="EMJ Oncology 2018 ePrint page 9" href="http://viewer.zmags.com/publication/5e9fb3a9?page=9"> An exercise survey was completed by patients at </a>
<a title="EMJ Oncology 2018 ePrint page 10" href="http://viewer.zmags.com/publication/5e9fb3a9?page=10"> The researchers found that the desire of in</a>
<a title="EMJ Oncology 2018 ePrint page 11" href="http://viewer.zmags.com/publication/5e9fb3a9?page=11"> Immune Checkpoint Inhibitors Effective in Mismatc</a>
<a title="EMJ Oncology 2018 ePrint page 12" href="http://viewer.zmags.com/publication/5e9fb3a9?page=12"> TNB cancers do not express oestrogen or HER</a>
<a title="EMJ Oncology 2018 ePrint page 13" href="http://viewer.zmags.com/publication/5e9fb3a9?page=13"> life; there are no paediatric trials for this dis</a>
<a title="EMJ Oncology 2018 ePrint page 14" href="http://viewer.zmags.com/publication/5e9fb3a9?page=14"> Unlike previous reports, the latest CheckMate-142</a>
<a title="EMJ Oncology 2018 ePrint page 15" href="http://viewer.zmags.com/publication/5e9fb3a9?page=15"> an increase in overall survival of 6.9 months (me</a>
<a title="EMJ Oncology 2018 ePrint page 16" href="http://viewer.zmags.com/publication/5e9fb3a9?page=16"> After the first year, results showed that 16.0% (n</a>
<a title="EMJ Oncology 2018 ePrint page 17" href="http://viewer.zmags.com/publication/5e9fb3a9?page=17"> PFS was 13.8 and 8.4 months, respectively (</a>
<a title="EMJ Oncology 2018 ePrint page 18" href="http://viewer.zmags.com/publication/5e9fb3a9?page=18"> Cancer Drug Reimbursement Approval Time Varies Ac</a>
<a title="EMJ Oncology 2018 ePrint page 19" href="http://viewer.zmags.com/publication/5e9fb3a9?page=19"> New ESMO Designated Centres of Integrated Oncolog</a>
<a title="EMJ Oncology 2018 ePrint page 20" href="http://viewer.zmags.com/publication/5e9fb3a9?page=20"> to the numerous successful breast cance</a>
<a title="EMJ Oncology 2018 ePrint page 21" href="http://viewer.zmags.com/publication/5e9fb3a9?page=21"> “It is so encouraging to see how precision</a>
<a title="EMJ Oncology 2018 ePrint page 22" href="http://viewer.zmags.com/publication/5e9fb3a9?page=22"> Congress Feature Summary of the ESMO 20</a>
<a title="EMJ Oncology 2018 ePrint page 23" href="http://viewer.zmags.com/publication/5e9fb3a9?page=23"> analysis in 521 randomised patients with a </a>
<a title="EMJ Oncology 2018 ePrint page 24" href="http://viewer.zmags.com/publication/5e9fb3a9?page=24"> Reflecting on the ever-increasing role o</a>
<a title="EMJ Oncology 2018 ePrint page 25" href="http://viewer.zmags.com/publication/5e9fb3a9?page=25"> Next were new insights into the treatment o</a>
<a title="EMJ Oncology 2018 ePrint page 26" href="http://viewer.zmags.com/publication/5e9fb3a9?page=26"> Events 16TH JANUARY 2019 23RD–25TH JANUARY 2019 </a>
<a title="EMJ Oncology 2018 ePrint page 27" href="http://viewer.zmags.com/publication/5e9fb3a9?page=27"> 7TH–9TH MARCH 2019 14TH–16TH MARCH 2019 </a>
<a title="EMJ Oncology 2018 ePrint page 28" href="http://viewer.zmags.com/publication/5e9fb3a9?page=28"> A Confident Choice for Total Cancer Care Freseni</a>